BioLight Life Sciences Statistics

Total Valuation

BioLight Life Sciences has a market cap or net worth of ILS 21.42 million. The enterprise value is 9.00 million.

Market Cap	21.42M
Enterprise Value	9.00M

Important Dates

The next estimated earnings date is Wednesday, November 27, 2024.

Earnings Date	Nov 27, 2024
Ex-Dividend Date	n/a

Share Statistics

BioLight Life Sciences has 4.66 million shares outstanding. The number of shares has increased by 1.16% in one year.

Current Share Class	n/a
Shares Outstanding	4.66M
Shares Change (YoY)	+1.16%
Shares Change (QoQ)	+1.20%
Owned by Insiders (%)	25.23%
Owned by Institutions (%)	22.59%
Float	1.97M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	108.17
PB Ratio	0.69
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-1.46
EV / Sales	45.47
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-1.01

Financial Position

The company has a current ratio of 4.39, with a Debt / Equity ratio of 0.03.

Current Ratio	4.39
Quick Ratio	4.39
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	-0.10
Interest Coverage	-9,952.00

Financial Efficiency

Return on equity (ROE) is -21.12% and return on invested capital (ROIC) is -17.70%.

Return on Equity (ROE)	-21.12%
Return on Assets (ROA)	-16.23%
Return on Capital (ROIC)	-17.70%
Revenue Per Employee	49,500
Profits Per Employee	-1.54M
Employee Count	4
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -15.92% in the last 52 weeks. The beta is 0.56, so BioLight Life Sciences's price volatility has been lower than the market average.

Beta (5Y)	0.56
52-Week Price Change	-15.92%
50-Day Moving Average	451.65
200-Day Moving Average	456.57
Relative Strength Index (RSI)	50.44
Average Volume (20 Days)	3,624

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BioLight Life Sciences had revenue of ILS 198,000 and -6.16 million in losses. Loss per share was -1.32.

Revenue	198,000
Gross Profit	198,000
Operating Income	-9.95M
Pretax Income	-7.31M
Net Income	-6.16M
EBITDA	-9.91M
EBIT	-9.95M
Loss Per Share	-1.32

Full Income Statement

Balance Sheet

The company has 13.42 million in cash and 846,000 in debt, giving a net cash position of 12.58 million or 2.70 per share.

Cash & Cash Equivalents	13.42M
Total Debt	846,000
Net Cash	12.58M
Net Cash Per Share	2.70
Equity (Book Value)	31.38M
Book Value Per Share	6.70
Working Capital	10.87M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -8.85 million and capital expenditures -22,000, giving a free cash flow of -8.87 million.

Operating Cash Flow	-8.85M
Capital Expenditures	-22,000
Free Cash Flow	-8.87M
FCF Per Share	-1.90

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-5,026.26%
Pretax Margin	-3,689.39%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-4,480.81%

Dividends & Yields

BioLight Life Sciences does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.16%
Shareholder Yield	-1.16%
Earnings Yield	n/a
FCF Yield	n/a

Stock Splits

The last stock split was on February 28, 2016. It was a reverse split with a ratio of 0.04.

Last Split Date	Feb 28, 2016
Split Type	Reverse
Split Ratio	0.04

Scores

BioLight Life Sciences has an Altman Z-Score of -6.81. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-6.81
Piotroski F-Score	n/a